1,842 results on '"Wilkoff, Bruce"'
Search Results
2. Managing Implanted Cardiac Electronic Devices in Patients With Severe Tricuspid Regurgitation: JACC State-of-the-Art Review
3. Mortality Benefit Among Primary Prevention Implantable Cardioverter-Defibrillator Recipients on Contemporary Heart Failure Treatment
4. High initial heart rate score is an independent predictor of new atrial high-rate episodes in pacemaker patients with sinus node dysfunction
5. Evaluating cardiac lead safety using observational, real-world data: EP PASSION proof-of-concept study
6. Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
7. Algorithms and programming matters: implantable cardioverter defibrillator therapy in Biotronik and Abbott devices
8. Implantable Cardioverter-Defibrillator for Primary Prevention in Asia
9. Clinical predictors of incomplete coronary sinus lead removal during transvenous lead extraction in patients with cardiac resynchronization therapy
10. Long-term outcomes in nonprogressors to cardiac resynchronization therapy
11. Mechanics of Lumenless Pacing Lead Strength During Extraction Procedures Based on Laboratory Bench Testing
12. Risk factors for hematoma in patients undergoing cardiac device procedures: A WRAP-IT trial analysis
13. Bradyarrhythmias detected by extended rhythm recording in patients undergoing transcatheter aortic valve replacement (Brady-TAVR Study)
14. Clinical performance of implantable cardioverter-defibrillator lead monitoring diagnostics
15. Comparing complication rates between Abbott Tendril 2088 and competitive manufacturer leads: Novel real‐world data approach.
16. Cybersecurity of Cardiac Implantable Electronic Devices
17. Novel ventricular tachyarrhythmia detection enhancement detects undertreated life-threatening arrhythmias
18. Risk Factors for CIED Infection After Secondary Procedures: Insights From the WRAP-IT Trial
19. Lower rate limit for pacing by cardiac resynchronization defibrillators: Should lower rate programming be reconsidered?
20. Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis
21. Comparison of outcomes and required tools between transvenous extraction of pacemaker and implantable cardioverter defibrillator leads: Insight from single high‐volume center experience
22. Failed Defibrillation with Unexpected Battery Depletion by Cable Externalization of Dual Coil Defibrillator Lead
23. In vitro modeling accurately predicts cardiac lead fracture at 10 years
24. Predictors of Cardiac Implantable Electronic Device Artifact on Cardiac MRI: The Utility of a Device Related Score
25. Dofetilide Dose Reductions and Discontinuation in Obese Compared with Nonobese Patients
26. Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Germany, Italy, and England
27. Low-temperature electrocautery reduces adverse effects from secondary cardiac implantable electronic device procedures: Insights from the WRAP-IT trial
28. List of contributors
29. Innovative Approaches and Technology Platforms for Pacemaker Lead Extraction
30. Heart rate score, a measure related to chronotropic incompetence in pacemaker patients
31. Clinical Presentation, Timing, and Microbiology of CIED Infections: An Analysis of the WRAP-IT Trial
32. Long-Term Outcomes in Patients With a Left Ejection Fraction ≤15% Undergoing Cardiac Resynchronization Therapy
33. Comparative Analysis of Procedural Outcomes and Complications Between De Novo and Upgraded Cardiac Resynchronization Therapy
34. 18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context:ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS
35. Competing risks of monomorphic vs. non-monomorphic ventricular arrhythmias in primary prevention implantable cardioverter–defibrillator recipients: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) study.
36. Transvenous lead extraction in patients with prior extraction procedures: Procedural profiles and outcomes
37. Use of virtual visits for the care of the arrhythmia patient
38. Cardiac venous injuries: Procedural profiles and outcomes during left ventricular lead placement for cardiac resynchronization therapy
39. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up
40. Baseline Right Ventricular Dysfunction Predicts Worse Outcomes in Patients Undergoing Cardiac Resynchronization Therapy Implantation
41. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
42. Lead Location as Assessed on Cardiac Computed Tomography and Difficulty of Percutaneous Transvenous Extraction
43. Heart rate score predicts mortality independent of shocks in ICD and CRT-D patients
44. HRS White Paper on interoperability of data from cardiac implantable electronic devices (CIEDs)
45. Transvenous Lead Extraction in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
46. Competitive athletes with implantable cardioverter–defibrillators—How to program? Data from the Implantable Cardioverter–Defibrillator Sports Registry
47. Effect of Cardiac Resynchronization Therapy on Left Ventricular Remodeling in Patients With Cardiac Sarcoidosis
48. Nomenclature, Definitions, and Metrics of Cardiovascular Implantable Electronic Device Lead Management
49. Overview of Lead Management
50. Extraction Outcomes of Implantable Cardioverter-Defibrillator Leads Vary by Manufacturer and Model Family
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.